PT Suparma Tbk Statistics

Total Valuation

PT Suparma Tbk has a market cap or net worth of IDR 939.92 billion. The enterprise value is 1.31 trillion.

Market Cap	939.92B
Enterprise Value	1.31T

Important Dates

The next estimated earnings date is Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	Jun 27, 2024

Share Statistics

PT Suparma Tbk has 3.15 billion shares outstanding.

Current Share Class	n/a
Shares Outstanding	3.15B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	81.63%
Owned by Institutions (%)	0.02%
Float	n/a

Valuation Ratios

The trailing PE ratio is 6.27.

PE Ratio	6.27
Forward PE	n/a
PS Ratio	0.35
PB Ratio	0.39
P/TBV Ratio	0.39
P/FCF Ratio	1.50
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.01, with an EV/FCF ratio of 2.09.

EV / Earnings	8.77
EV / Sales	0.49
EV / EBITDA	4.01
EV / EBIT	6.10
EV / FCF	2.09

Financial Position

The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.23.

Current Ratio	3.25
Quick Ratio	0.91
Debt / Equity	0.23
Debt / EBITDA	1.72
Debt / FCF	0.90
Interest Coverage	5.78

Financial Efficiency

Return on equity (ROE) is 6.39% and return on invested capital (ROIC) is 4.47%.

Return on Equity (ROE)	6.39%
Return on Assets (ROA)	3.99%
Return on Capital (ROIC)	4.47%
Revenue Per Employee	3.37B
Profits Per Employee	189.37M
Employee Count	779
Asset Turnover	0.79
Inventory Turnover	2.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.86% in the last 52 weeks. The beta is 0.69, so PT Suparma Tbk's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	-14.86%
50-Day Moving Average	306.92
200-Day Moving Average	309.57
Relative Strength Index (RSI)	44.04
Average Volume (20 Days)	287,300

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Suparma Tbk had revenue of IDR 2.67 trillion and earned 149.80 billion in profits. Earnings per share was 47.49.

Revenue	2.67T
Gross Profit	426.27B
Operating Income	215.09B
Pretax Income	200.19B
Net Income	149.80B
EBITDA	320.00B
EBIT	215.09B
Earnings Per Share (EPS)	47.49

Full Income Statement

Balance Sheet

The company has 189.46 billion in cash and 562.58 billion in debt, giving a net cash position of -373.12 billion or -118.30 per share.

Cash & Cash Equivalents	189.46B
Total Debt	562.58B
Net Cash	-373.12B
Net Cash Per Share	-118.30
Equity (Book Value)	2.40T
Book Value Per Share	759.79
Working Capital	965.53B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 658.27 billion and capital expenditures -31.19 billion, giving a free cash flow of 627.07 billion.

Operating Cash Flow	658.27B
Capital Expenditures	-31.19B
Free Cash Flow	627.07B
FCF Per Share	198.81

Full Cash Flow Statement

Margins

Gross margin is 15.98%, with operating and profit margins of 8.06% and 5.61%.

Gross Margin	15.98%
Operating Margin	8.06%
Pretax Margin	7.50%
Profit Margin	5.61%
EBITDA Margin	11.99%
EBIT Margin	8.06%
FCF Margin	23.50%

Dividends & Yields

This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 4.03%.

Dividend Per Share	12.00
Dividend Yield	4.03%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	25.21%
Buyback Yield	n/a
Shareholder Yield	4.03%
Earnings Yield	15.94%
FCF Yield	66.72%

Dividend Details

Stock Splits

The last stock split was on June 15, 2022. It was a forward split with a ratio of 1.13.

Last Split Date	Jun 15, 2022
Split Type	Forward
Split Ratio	1.13

Scores

PT Suparma Tbk has an Altman Z-Score of 2.52. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.52
Piotroski F-Score	n/a